Efficacy and safety of intravenous immunoglobulin with rituximab versus rituximab alone in childhood-onset steroid-dependent and frequently relapsing nephrotic syndrome: protocol for a multicentre randomised controlled trial.
Julien HoganAubriana PerezAnne-Laure Sellier-LeclercIsabelle VrillonFrancoise BrouxFrancois NobiliJerome HarambatLucie BessenayV AudardCamille FaudeuxDenis MorinChristine PietrementStephanie TellierDjamal DjeddiPhilippe EckartAnnie LahocheG Roussey-KeslerTim UlinskiOlivia BoyerEmmanuelle PlaisierSylvie CloarecAnne JolivotVincent GuigonisSophie Guilmin-CreponVeronique BaudouinClaire DossierGeorges DeschênesPublished in: BMJ open (2020)
NCT03560011.